WebMD: Better Information. Better Health.
  • Bookmark This Page
  • Site Map
  • Sign up for WebMD Newsletters

Brain Cancer Health Center

Font Size
A
A
A

Neuroblastoma Screening (PDQ®) - Summary of Evidence

Note: Separate PDQ summaries on Neuroblastoma Treatment and Levels of Evidence for Cancer Screening and Prevention Studies are also available.

Intervention

Screening, usually at age 6 months, for urine vanillylmandelic acid and homovanillic acid, which are metabolites of the hormones norepinephrine and dopamine.

Benefits

Based on solid evidence, screening for neuroblastoma does not lead to decreased mortality.

Description of the Evidence

  • STUDY DESIGN: Evidence obtained from nonrandomized controlled trials.
  • INTERNAL VALIDITY: Good.
  • CONSISTENCY: Good.
  • MAGNITUDE OF EFFECTS ON HEALTH OUTCOMES: No effect on mortality.
  • EXTERNAL VALIDITY: Fair.

Harms

Based on solid evidence, screening infants for neuroblastoma leads to an increase in incidence of early-stage neuroblastoma. There is no concurrent decrease in incidence in screened children of advanced-stage disease, which typically does poorly, or of incidence in children older than 1 year. The cases identified by screening almost exclusively have biologically favorable properties.

Based on solid evidence, screening infants for neuroblastoma results in overdiagnosis (diagnosis of some neuroblastomas detectable by mass screening that would not have been clinically diagnosed later). This leads to unnecessary diagnostic and therapeutic procedures with consequent physical and psychological morbidity, including death from treatment complications.

Description of the Evidence

  • STUDY DESIGN: Evidence obtained from nonrandomized controlled trials.
  • INTERNAL VALIDITY: Good.
  • CONSISTENCY: Good.
  • MAGNITUDE OF EFFECTS ON HEALTH OUTCOMES: No effect on mortality. Screening may overdiagnose as many as 7 cases per 100,000 infants screened.
  • EXTERNAL VALIDITY: Fair.

WebMD Public Information from the National Cancer Institute

This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER

Last Updated: December 20, 2006
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Next Article:
webMD Video

click to expand/contract  Brain Tumor Vaccine

When cancer strikes the brain, it's deadly. But an experimental vaccine may help patients live longer.

Watch Video

click to expand/contract  Life After a Brain Tumor

click to expand/contract  New Generation PET Scanner

click to expand/contract  Cancer Pain Scale

click to expand/contract  Chemotherapy and the Brain

Most Popular Stories